Par Sterile Products LLC is recalling 466 vials of Treprostinil Injection, 20 mg/20 mL (1 mg/mL), due to the presence of particulate matter. This medication is used for subcutaneous or intravenous infusion and was distributed nationwide. Injecting a product containing foreign particles can lead to serious health complications, such as blood vessel blockages or inflammation.
The presence of particulate matter in an injectable drug poses a risk of vascular occlusion, embolism, or inflammatory reactions. These particles can cause local irritation or systemic damage if they travel through the bloodstream.
Distributed by Par Pharmaceutical, Chestnut Ridge, NY 10977.
Label, Par Pharmaceutical Treprostinil 20mg/20mL Injection.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.